title: Targeted in vivo imaging of angiogenesis: present status and perspectives.
abstract: Angiogenesis, the process whereby new capillaries are formed by outgrowth from existing microvessels, is required for tumor growth and metastasis, and is also necessary for natural healing after ischemic injury. Because angiogenesis, excessive or deficient, underlies many pathological situations, there is a need for the development of noninvasive imaging to allow monitoring of angiogenesis related molecular events. Furthermore, specific imaging of angiogenesis would help define the pathophysiology of angiogenesis in living subjects, identify those patients likely to respond to anti-angiogenic or angiogenic therapies, and enable the efficacies of these molecular therapies to be assessed. Herein, we review the targeted imaging of angiogenesis using nuclear medicine modalities (positron emission tomography; PET and single photon emission computed tomography; SPECT) and suitable radiotracers based on potential targets including integrin, extracellular matrix, VEGF and its receptors, activated endothelial cells, and matrix metalloproteinases.
authors.affiliation: Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: Yearn Seong
authors.initials: YS
authors.lastname: Choe
authors.forename: Kyung-Han
authors.initials: KH
authors.lastname: Lee
mesh_terms: D043924:Angiogenesis Modulating Agents / Q000494:pharmacology; D000818:Animals; D042783:Endothelial Cells / Q000000981:diagnostic imaging / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D006801:Humans; D016023:Integrins / Q000378:metabolism; D007511:Ischemia / Q000000981:diagnostic imaging / Q000378:metabolism; D020782:Matrix Metalloproteinases / Q000378:metabolism; D015394:Molecular Structure; D009369:Neoplasms / Q000098:blood supply / Q000000981:diagnostic imaging / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000000981:diagnostic imaging* / Q000378:metabolism; D018919:Neovascularization, Physiologic / Q000187:drug effects; D049268:Positron-Emission Tomography / Q000639:trends; D019275:Radiopharmaceuticals / Q000737:chemistry* / Q000378:metabolism*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000378:metabolism; D015899:Tomography, Emission-Computed, Single-Photon / Q000639:trends; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
chemical_list: D043924:Angiogenesis Modulating Agents; D016326:Extracellular Matrix Proteins; D016023:Integrins; D019275:Radiopharmaceuticals; D042461:Vascular Endothelial Growth Factor A; D040262:Receptors, Vascular Endothelial Growth Factor; D020782:Matrix Metalloproteinases